Product Name | MF | CAS | Details |
---|
Murizatoclax | C42H57ClN4O5S | 2245848-05-7 | Details |
PDE5-IN-2 | C25H21N3O6S | 2244517-61-9 | Details |
DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
Alvameline maleate | C13H19N5O4 | 219581-36-9 | Details |
PARP-2-IN-1 | C21H19F4N5O3 | 2115698-83-2 | Details |
RORγt agonist 1 | C24H17F6NO5S | 2377378-89-5 | Details |
GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
Phortress free base | C20H23FN4OS | 741241-36-1 | Details |
Levomecol | C16H18Cl2N4O7 | 118573-58-3 | Details |
LBW242 | C27H42N4O2 | 867324-12-7 | Details |
Ppc-1 | C21H25NO4 | 1245818-17-0 | Details |
TP3011 | C26H26N4O5 | 534605-74-8 | Details |
Atiratecan | C31H34N6O6 | 867063-97-6 | Details |
BIZ 114 | C24H40O3 | 2099120-74-6 | Details |
DC-5163 | C18H20ClN3OS | 897771-47-0 | Details |
Integrin-IN-2 | C27H30N4O3 | 2378617-67-3 | Details |
RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
RORγt Inverse agonist 2 | C27H25F8NO5S | 1801197-92-1 | Details |
BN201 | C25H38FN5O4 | 1361200-34-1 | Details |
Atopaxar hydrochloride | C29H39ClFN3O5 | 474544-83-7 | Details |
20681-S | C21H29NO5S | 73361-71-4 | Details |
QPX7728 bis-acetoxy methyl ester | C15H14BFO8 | 2170834-56-5 | Details |
D-Cl-amidine | C14H19ClN4O2 | 1404060-15-6 | Details |
JAK-IN-4 | C18H22N4NaO6P | 1400877-37-3 | Details |
VBIT-3 | C21H19ClF3N3O3 | 2088463-66-3 | Details |
Pulrodemstat Methylbenzenesulfonate | C31H31F2N5O5S | 2097523-57-2 | Details |
TP-004 | C17H16F3N5O | 1454299-21-8 | Details |
(R)-OR-S1 | C26H34BrN3O4 | 1809336-19-3 | Details |
Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
Py-MPB-amino-C3-PBD | C41H44N8O6 | 2412924-07-1 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
5-Hydroxylansoprazole sulfone | C16H14F3N3O4S | 131927-00-9 | Details |
OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
Mebeverine alcohol D5 | C16H27NO2 | 2070015-15-3 | Details |
Fobrepodacin disodium | C21H27FN6NaO6P | 1384984-20-6 | Details |
PF-06795071 | C18H17F4N3O3 | 2075629-81-9 | Details |
PKR activator 2 | C18H16N8OS | 2283422-04-6 | Details |
A-424274 | C14H15N3 | 1335145-56-6 | Details |
7-Deoxyloganic acid | C16H24O9 | 22487-36-1 | Details |
BMS-986163 | C23H28FN2O5P | 1801151-09-6 | Details |
Tecovirimat hydrate | C19H17F3N2O4 | 1162664-19-8 | Details |
A2B57 | C22H19N5O | 1602733-73-2 | Details |
OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
Isoproterenol bitartrate | C11H17NO3.C4H6O6 | 59-60-9 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
(S)-BI 665915 | C24H26N8O2 | 1360550-05-5 | Details |
MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
CYT-1010 hydrochloride | C35H41ClN6O5 | 1161517-81-2 | Details |
PKR activator 1 | C16H14N8OS2 | 2283420-62-0 | Details |
58-G3 | C14H12Cl2N4O5 | 287174-44-1 | Details |
PDE1-IN-3 | C18H24N4O | 2370966-46-2 | Details |
Isoxsuprine-monoester-1 | C23H31NO4 | 67160-74-1 | Details |
GLPG-3221 | C30H37F3N2O6 | 2222264-64-2 | Details |
AN11251 | C29H38BFO7 | 2130750-59-1 | Details |
13-Hydroxystevane | C20H34O | 5749-44-0 | Details |
Turbinaric acid | C27H44O2 | 56882-00-9 | Details |
(S)-Gyramide A | C21H27FN2O3S | 1000592-48-2 | Details |
NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
Oxaquin | C31H33F2N4O11P | 790704-50-6 | Details |
(+)-SHIN1 | C24H24N4O2 | 2443966-90-1 | Details |
JBJ-02-112-05 | C27H20N4O2S | 2748162-29-8 | Details |
gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
Tyk2-IN-9 | C20H17N9 | 2127109-85-5 | Details |
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
SLLN-15 | C19H23N7Se2 | 2403650-93-9 | Details |
UB 165 fumarate | 2454492-43-2 | Details |
(Rac)-PF-06250112 | C22H20F2N6O2 | 1609465-88-4 | Details |
TLC3407-3786 | C19H19N3O4 | 896356-25-5 | Details |
VDR agonist 1 | C32H51N3O2 | 2269494-43-9 | Details |
Syk-IN-3 | C24H28N4O3S | 1312534-69-2 | Details |
OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
(+/-)-Terreic acid | C7H6O4 | 15255-24-0 | Details |
Bocconoline | C22H21NO5 | 1322007-90-8 | Details |
JMV 2959 hydrochloride (925238-89-7 free base) | 2448414-54-6 | Details |
Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
Lesopitron HCl | 132449-88-8 | Details |
CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
Cdc7-IN-3 | C20H22N4O5 | 1402057-87-7 | Details |
CP5V | C46H66Cl3N9O12S | 2509359-75-3 | Details |
Cdc7-IN-4 | C22H24F3N5O4 | 1402059-21-5 | Details |
Chitinase-IN-2 hydrochloride | C20H22ClN5O2S | 2070014-83-2 | Details |
CD235 | C26H20FN5O2 | 1627716-57-7 | Details |
PPTN | C29H24F3NO2 | 1160271-30-6 | Details |
TT-232 TFA(147159-51-1 free base) | 2703745-48-4 | Details |
AY 9944 dihydrochloride | C22H28Cl2N2 | 1245-84-7 | Details |
Asteltoxin | C23H30O7 | 79663-49-3 | Details |
A1B11 | C22H25N5O | 1602731-56-5 | Details |
Product Total: Product Page: | ||||
138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |